Mesenchymal stem cell bioreactor for the active treatment of acute renal failure

Ended Project Grant Awarded Last action

Award ID
R44DK085766
Recipient
Awarding agency
Obligated
$3,583,968

Award facts

Assistance listing
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
Completion date
Originally
Place of performance
Medford, MA 02155, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$175,266
Amendment $962,626
Amendment $1,006,437
Amendment Transforming dialysis into a controlled drug delivery system for stem cell derive $1,016,886
Original award $773,285

Quick answers

Who received award R44DK085766?

R44DK085766 was awarded to Sentien Biotechnologies, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on June 15, 2010.

How much is award R44DK085766 worth?

$3,583,968 has been obligated on R44DK085766.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award